Athira Pharma Falls 40% Amid Questions About CEO's PhD Research

·

·

Athira Pharma Falls 40% Amid Questions About CEO's PhD Research

Just a bit more than a week ago, the small, Alzheimers-focused biotech Athira Pharma was a high flier, shooting up 13% in the first few hours of trading on June 7 after the U.S. Food and Drug Administration’s controversial approval of Biogen’s Alzheimer’s …
See Original Article

5 things to know before the stock market opens Friday

Here are the most important news, trends and analysis that investors need to start their trading day: Dow looks to avoid first five-session losing streak since January; 10-year yield continues to give up Wednesday’s Fed-driven spike; Many commodities bounce, …
See Original Article

Pro Bankruptcy Briefing: Boy Scouts Near Abuse Deal Amid Michigan Probe; Top Firm Kirkland Sheds Bankruptcy …

Good day. The Boy Scouts of America are nearing a settlement with a group of sex-abuse survivors, while facing a probe by Michigan authorities that could last beyond the youth group’s bankruptcy case. And the leading bankruptcy practice at Kirkland & Ellis …
See Original Article

Massachusetts median home sale price stays above $500000

“Condos continued to rebound in May as life in urban centers continued to get back to normal,” Warren said. “If activity in the condo market continues at this clip, I fully expect the median sale price of both single-family homes and condos to surpass $500,000 in …
See Original Article

Zuckerberg's Decline In Popularity Has Important Lessons For Business Leaders

Like the stock market, the reputations of business leaders have their ups and downs, which has certainly been the case for Mark Zuckerberg. Unfortunately for the CEO of Facebook, his reputation has lately suffered more downs than ups. The newest hit to …
See Original Article



Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.